Browse Acetaminophen Content

Awareness of acetaminophen safe use and the risks of using too much remains high, indicating that ongoing education is critical to continued progress.

Jun 6, 2022

We don't often think about insurance coverage for OTC medicines, but more and more health plans are offering this benefit. In this episode, we'll explore what new research is telling us about this and why Medicare Advantage is a big opportunity for self-care.

Mar 21, 2022

Anita Brikman sits down with board-certified pediatrician and co-founder of Forever Freckled, Dr. Katie Friedman to discuss the rise of the healthcare social media influencer.

Sep 6, 2021

Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.

Feb 4, 2021

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.

Jan 23, 2020

Acetaminophen was chosen for review by OEHHA in part because the Prop 65 regulation emphasizes chemicals with “widespread exposure.” The Carcinogen Identification Committee will review the information on acetaminophen and cancer to determine whether acetaminophen should be listed as a carcinogen under Proposition 65.

Jan 16, 2020

FDA has determined that the currently available evidence does not support the conclusion that acetaminophen causes cancer. Accordingly, a Proposition 65 cancer warning on the labeling of products containing acetaminophen would not be scientifically accurate, and such labeling would be false or misleading.

Dec 13, 2019

We strongly urge the CIC not to “list” acetaminophen as a carcinogen due to the lack of evidence that it has been “clearly shown” to cause cancer, and due to the unnecessary confusion and fear it could cause among consumers and patients.

Nov 5, 2019

This information is submitted on behalf of CHPA in response to the September 20, 2019 OEHHA notice: Announcement of the Carcinogen Identification Committee Meeting Scheduled for December 5, 2019, Notice of Availability of Hazard Identification Materials for Acetaminophen and Notice of Public Comment Period.

Nov 4, 2019

CHPA supports and encourages continued research and promotes ongoing consumer education to help ensure safe use of OTC medicines.

Nov 1, 2019

Filter Results